Materials for medicine reassessment get stricter
In the future, when applying for reassessment for a novel drug, a pharmaceutical company must turn in reference data, such as sales and approval records.
On 21 November, the Ministry of Food and Drug Safety(MFDS) officially announced a partial revision to the ‘Reassessment Standards for Novel Dr...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
